SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's recent performance and future outlook are under scrutiny, with community chatter focusing on the company's earnings call and the potential impact of tariffs. Concerns about Elon Musk's commentary and the company's AI/robotics progress are driving bearish sentiment. Bulls remain hopeful, anticipating positive developments from Tesla's ventures beyond traditional car manufacturing.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending as community members discuss the CEO's comments regarding Phase 3 oral trials and potential M&A interest in their NASH assets. The enthusiasm is fueled by optimism for Viking's obesity and metabolic pipeline, with some drawing parallels to previous acquisitions in the biotech space. Community members are actively debating whether the stock is currently undervalued amidst short-term volatility.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending following positive reports regarding its quantum computing capabilities and a partnership with HSBC to improve bond trading predictions, with some community members speculating this is the beginning of a larger upward trend.  The stock is experiencing increased attention and bullish sentiment, especially as it positions itself in the AI and quantum computing sectors. Some investors believe that IBM is undervalued, given its strong position in quantum computing and AI, and is a safer bet compared to pure-play quantum stocks.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors digest the latest earnings report and assess the company's progress towards commercialization. The community is focused on potential partnerships with automotive OEMs, especially following Elon Musk's comments on new battery tech, and the significance of customer billings. While some express concerns about the company's cash burn and lack of revenue, others remain optimistic about its long-term potential in the solid-state battery market.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene ($CNC) is trending as investors react to Molina's ($MOH) earnings miss, with some seeing it as a buying opportunity while others express concern about the broader sector; the community is debating whether the dip is an overreaction or a sign of deeper issues, with some expecting a rebound and others remaining cautious until 2026.

Houston American Energy Corp. is an independent oil and gas company, which engages in the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. The firm holds interest in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region and in the South American country of Colombia. It operates through the North America and South America geographical segments. The company was founded on April 2, 2001 and is headquartered in Houston, TX.

Houston American Energy Corp

Houston American Energy ($HUSA) is trending as traders discuss its potential amid ongoing geopolitical tensions and fluctuations in oil prices. Community members are weighing the possibility of a short squeeze, while others cite concerns about dilution and past performance. The stock remains an active point of discussion among traders focused on energy and micro-cap plays.

Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.

Molina Healthcare Inc

MOH is trending due to lowered annual profit forecasts, driven by unexpectedly high medical costs, particularly within its Obamacare Marketplace business, sparking discussion around cost spirals impacting health insurers. Community sentiment appears negative, with some anticipating further declines and comparing MOH unfavorably to competitors. The news has triggered broader concerns about the healthcare sector's financial health and potential impacts on premiums.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

LRCX is trending due to positive Q126 earnings results and forward guidance, sparking discussions around AI chip production and tariff impacts. Community members are actively debating the company's growth potential, particularly in relation to China's market and competition, with some eyeing specific price milestones while acknowledging potential risks.

Beasley Broadcast Group, Inc. is multi-platform media company, which engages in the operation of radio stations in the United States. The firm offers marketing solutions across event platforms. It operates through the following business segments: Audio, Digital, and Other. The company was founded by George G. Beasley in 1961 and is headquartered in Naples, FL.

Beasley Broadcast Group Inc - Ordinary Shares - Class A

Beasley Broadcast Group is trending as traders discuss its potential as the next low float runner, citing its small float and increasing volume. The community is watching for a breakout, with some eyeing a move towards a key moving average. Recent low float runners are also being referenced as potential catalysts.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending downwards amidst a broader sell-off in quantum computing stocks, sparked by competitor advancements; the community is debating whether this is a temporary correction or a sign of overvaluation, with some highlighting high short interest and potential manipulation, while others point to upcoming earnings and long-term growth potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Medical Stocks Lagging  Armata Pharmaceuticals (ARMP) This Year?

Here is how Armata Pharmaceuticals, Inc. (ARMP) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.

Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year?

Here is how Armata Pharmaceuticals, Inc. (ARMP) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.

Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?

Here is how Arbutus Biopharma (ABUS) and Armata Pharmaceuticals, Inc. (ARMP) have performed compared to their sector so far this year.

All You Need to Know About Armata Pharmaceuticals (ARMP) Rating Upgrade to Buy

Armata Pharmaceuticals (ARMP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is Armata Pharmaceuticals (ARMP) Outperforming Other Medical Stocks This Year?

Here is how Armata Pharmaceuticals, Inc. (ARMP) and Avadel (AVDL) have performed compared to their sector so far this year.

Armata Pharmaceuticals, Inc. (ARMP) Reports Q2 Loss, Beats Revenue Estimates

Armata Pharmaceuticals (ARMP) delivered earnings and revenue surprises of +17.95% and +57.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

ARMP Soars 72% in a Month Following Infectious Disease Study Success

Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue Estimates

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates

Sangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue Estimates

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.

Current Price	$7.05
Prev Close	$3.47
Open	$3.50
Dividend Yield	0.00%
50-Day Moving Average	$2.93
Beta	0.45
Avg. Volume	11,492.90
PE Ratio	-4.70

52-Week High	$3.50
52-Week Low	$0.8981
Market Capitalization	$125.72M
EPS (Annual)	-$0.5231
Price to Book	-1.81
Revenue Per Employee	$86,233.33
Enterprise Value/EBITDA	N/A

ARMP
Armata Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ARMP News

ARMPArmata Pharmaceuticals Inc